| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ricardo Ulises Macías-Rodríguez, Alberto Adrián Solís-Ortega, Victoria J Ornelas-Arroyo, Astrid Ruiz-Margáin, Maria Sarai González-Huezo, Nestor A Urdiales-Morán, Berenice M Román-Calleja, Juan M Mayorquín-Aguilar, José A González-Regueiro, Alejandro Campos-Murguía, Israel Vicente Toledo-Coronado, Mónica Chapa-Ibargüengoitia, Bernardo Valencia-Peña, Carlos Fernando Martínez-Cabrera and Nayelli C Flores-García |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ricardo Ulises Macías-Rodríguez, MD, MSc, PhD, Assistant Professor, Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Col. Belisario Domínguez Sección XVI, Liver Fibrosis and Nutrition Lab (LFN-Lab). MICTLÁN Network: Mechanisms of Liver Injury, Cell Death and Translational Nutrition in Liver Diseases-Research Network, Mexico City 14080, Mexico. ricardomacro@yahoo.com.mx |
| Key Words |
COVID-19; Metabolic associated fatty liver disease; Lactate dehydrogenase; Transaminases; Prognosis; Non-alcoholic fatty liver disease |
| Core Tip |
The lactate dehydrogenase (LDH) and transaminases aspartate aminotransferase/alanine aminotransferase (AST/ALT) in patients with coronavirus disease 2019 (COVID-19) and metabolic associated fatty liver disease (LFN-COVID-19 index) index is a new prognostic index, that includes serum LDH, AST and ALT levels, developed to specifically predict adverse clinical outcomes including mortality, in patients with metabolic-associated fatty liver disease and COVID-19. The variables included in this index, allow an easy, quick and reliable risk assessment in this population with simple markers, allowing for broad implementation. |
| Publish Date |
2022-09-29 10:42 |
| Citation |
Macías-Rodríguez RU, Solís-Ortega AA, Ornelas-Arroyo VJ, Ruiz-Margáin A, González-Huezo MS, Urdiales-Morán NA, Román-Calleja BM, Mayorquín-Aguilar JM, González-Regueiro JA, Campos-Murguía A, Toledo-Coronado IV, Chapa-Ibargüengoitia M, Valencia-Peña B, Martínez-Cabrera CF, Flores-García NC. Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19. World J Gastroenterol 2022; 28(37): 5444-5456 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i37/5444.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i37.5444 |
